Reconsidering recent myocardial infarction as a contraindication for IV stroke thrombolysis

被引:26
作者
De Silva, D. A. [1 ]
Manzano, J. J. F. [1 ]
Chang, H. M. [1 ]
Wong, M. C. [2 ]
机构
[1] Singapore Gen Hosp, Dept Neurol, Singapore 169608, Singapore
[2] Minist Hlth, NMRC, Singapore, Singapore
关键词
ACUTE ISCHEMIC-STROKE; CARDIAC RUPTURE; INTRAVENOUS THROMBOLYSIS; HEMOPERICARDIUM; TAMPONADE; EFFICACY; THERAPY;
D O I
10.1212/WNL.0b013e31821ccc72
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: We reviewed the literature on IV stroke thrombolysis for patients with recent myocardial infarction (MI). Methods: We searched PubMed and Ovid databases, relevant trials, and guidelines. Results: Only 5 thrombolyzed stroke patients with recent MI were reported to have cardiac tamponade. Pathological studies show MI healing is completed by 7 weeks. Conclusion: The time window from MI as a contraindication for IV stroke thrombolysis may be narrowed from 3 months in current guidelines to 7 weeks. Neurology (R) 2011;76:1838-1840
引用
收藏
页码:1838 / 1840
页数:3
相关论文
共 29 条
[1]   Guidelines for the early management of adults with ischemic stroke - A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups [J].
Adams, Harold P., Jr. ;
del Zoppo, Gregory ;
Alberts, Mark J. ;
Bhatt, Deepak L. ;
Brass, Lawrence ;
Furlan, Anthony ;
Grubb, Robert L. ;
Higashida, Randall T. ;
Jauch, Edward C. ;
Kidwell, Chelsea ;
Lyden, Patrick D. ;
Morgenstern, Lewis B. ;
Qureshi, Adnan I. ;
Rosenwasser, Robert H. ;
Scott, Phillip A. ;
Wijdicks, Eelco F. M. .
STROKE, 2007, 38 (05) :1655-1711
[2]  
[Anonymous], 2010, NEUROL TODAY
[3]   CARDIAC RUPTURE - CHALLENGE IN DIAGNOSIS AND MANAGEMENT [J].
BATES, RJ ;
BEUTLER, S ;
RESNEKOV, L ;
ANAGNOSTOPOULOS, CE .
AMERICAN JOURNAL OF CARDIOLOGY, 1977, 40 (03) :429-437
[4]   Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists - Observations from the thrombolysis and thrombin inhibition in myocardial infarction 9 study [J].
Becker, RC ;
Hochman, JS ;
Cannon, CP ;
Spencer, FA ;
Ball, SP ;
Rizzo, MJ ;
Antman, EM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (02) :479-487
[5]   CARDIAC RUPTURE ASSOCIATED WITH THROMBOLYTIC THERAPY - IMPACT OF TIME TO TREATMENT IN THE LATE ASSESSMENT OF THROMBOLYTIC EFFICACY (LATE) STUDY [J].
BECKER, RC ;
CHARLESWORTH, A ;
WILCOX, RG ;
HAMPTON, J ;
SKENE, A ;
GORE, JM ;
TOPOL, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (05) :1063-1068
[6]   A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction [J].
Becker, RC ;
Gore, JM ;
Lambrew, C ;
Weaver, WD ;
Rubison, RM ;
French, WJ ;
Tiefenbrunn, AJ ;
Bowlby, LJ ;
Rogers, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (06) :1321-1326
[7]  
Cotran R.S., 1989, PATHOLOGIC BASIS DIS
[8]  
DHAND A, NEUROCRIT CARE
[9]  
*EMC, 2009, ACT SUMM PROD CHAR
[10]  
Factor S M, 1987, Am J Cardiovasc Pathol, V1, P91